(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk's acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to…
(IN BRIEF) Tubulis has closed an oversubscribed €128 million ($138.8 million) Series B2 financing round, co-led by EQT Life Sciences…